AD
Retigabine Dihydrochloride(CAS: 150812-13-8)
CAS Number
Related Products
![Ethyl 4-(2-{4,5-bis[4-(ethoxycarbonyl)phenyl]-1,3-dithiol-2-ylidene}-5-[4-(ethoxycarbonyl)phenyl]-1,3-dithiol-4-yl)benzoate](https://static.chemtradehub.com/structs/135/1356336-61-2-b5d1.webp)
![1-[(3aS,8aS)-2,2-Dimethyl-4,4,8,8-tetraphenyltetrahydro[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepin-6-yl]piperidine](https://static.chemtradehub.com/structs/582/582300-11-6-7e49.webp)
![2-[(5-Phenyl-2-pyrimidinyl)amino]ethanol](https://static.chemtradehub.com/structs/298/298217-37-5-72d8.webp)
Other Suppliers for Retigabine Dihydrochloride
Basic Information
Molecular Formula
C16H20Cl2FN3O2
Molecular Weight
376.2 g/mol
Physical Properties
Melting Point
168-170°C
Chemical Identifiers
SMILES
CCOC(=O)NC1=C(C=C(C=C1)NCC2=CC=C(C=C2)F)N.Cl.Cl
InChIKey
WSGFOWNASITQHJ-UHFFFAOYSA-N
Database References
FAQ
Retigabine dihydrochloride is an anti-epileptic drug. It is a derivative of retigabine, which is used to treat epilepsy by modulating the potassium channels in the brain.
Retigabine dihydrochloride is primarily used as an antiepileptic medication to treat partial-onset seizures in patients with epilepsy. It is also used in research for its effects on potassium channels.
Retigabine dihydrochloride is generally considered safe when used as directed. However, it may cause side effects such as dizziness and headache. It is important to follow the prescribed dosage and consult a healthcare provider if any adverse effects are experienced.
Retigabine dihydrochloride should be stored at room temperature (15-30°C) and protected from moisture and light. It should be kept in a tightly sealed container to maintain its efficacy.
Safety Notice
Please verify product specifications and safety data before use. Contact the supplier for detailed safety information.
Always follow proper handling procedures
Contact Information
shenlinxing@macklin.cn
Mobile
15221275939
Telephone
021-50706066
Fax
021-50706099
Visit Website
https://www.macklin.cn